<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:18:36Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/27804" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/27804</identifier><datestamp>2026-09-24T20:52:26Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Holloway, Alison</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Martínez, Annia</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Health Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2022-09-13T18:29:27Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2022-09-13T18:29:27Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2022-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/27804</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/7699</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">This thesis is prepared in the “sandwich” format as outlined in the “Guide for the &#xd;
preparation of Master’s and Doctoral Theses” available through the School of &#xd;
Graduate Studies at McMaster University. Chapter 1 consists of a general &#xd;
introduction for the entire body of work. Sections of this chapter have been published &#xd;
in a review article (doi.org/10.3390/ijms22168576). Chapters 2, 3 and 4 consist of &#xd;
reprints of original research articles, all published at the time of thesis submission. &#xd;
Chapter 5 includes a general discussion, limitations and future directions of this &#xd;
research project. The author of this thesis is also the first author of all four published &#xd;
articles included.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">As cannabis use increases, it is important to understand its impact on human health. &#xd;
Particularly, the effect of cannabis constituents on female reproductive health and the &#xd;
long-term effects on the offspring, when used during pregnancy, are not fully understood. &#xd;
The goal of this thesis was to address this knowledge gap by evaluating the impact of &#xd;
delta-9-tetrahydrocannabinol (THC), the psychoactive component of cannabis, on &#xd;
ovarian health and function, focusing on the long-term effects of prenatal exposure and &#xd;
the underlying mechanisms. Gestational THC exposure resulted in altered follicle &#xd;
dynamics, decreased vascularization and increased follicular apoptosis in the adult rat &#xd;
ovary. These alterations were associated with changes in ovarian miRNA and mRNA &#xd;
expression, as well as altered protein levels of important regulating factors. Specifically, &#xd;
prenatal THC exposure increased the expression of miR-122-5p and decreased the &#xd;
expression of its target gene insulin-like growth factor 1 receptor (IGF-1R), involved in the &#xd;
regulation of folliculogenesis, angiogenesis, and granulosa cell proliferation and &#xd;
apoptosis. Reduced vascularization in THC-exposed ovaries was also associated with &#xd;
decreased expression of the angiogenic factor vascular endothelial growth factor (VEGF) &#xd;
and its receptor (VEGFR-2), as well as increased expression of the antiangiogenic factor &#xd;
thrombospondin 1 (TSP-1). The differential expression of these important factors, along &#xd;
with the decreased vascularization and increased follicular apoptosis may partially explain &#xd;
the follicle dynamics observed in prenatally THC-exposed rats at 6 months of age, as they &#xd;
had accelerated folliculogenesis with follicular development arrest, which could lead to &#xd;
premature reproductive senescence. The direct impact of THC on rat ovarian explants &#xd;
and granulosa cells was also evaluated, revealing similarities and differences between the in utero, ex vivo and in vitro models. Taken together, our results indicate that &#xd;
cannabis constituents have the ability to alter key pathways in the developing ovary &#xd;
that may lead to detrimental effects on female reproductive health and fertility.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (Medical Science)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">The use of cannabis by pregnant women and women of reproductive age has &#xd;
increased considerably during the past decades, particularly in developed countries. &#xd;
This thesis evaluated the impact of delta-9-tetrahydrocannabinol (THC), the &#xd;
psychoactive component of cannabis, on ovarian health and function, with a focus &#xd;
on gestational exposure. Our results suggest that cannabis use during pregnancy &#xd;
may have detrimental effects on the offspring’s reproductive health, as prenatal THC &#xd;
exposure resulted in altered ovarian follicle dynamics, decreased vascularization &#xd;
and increased follicular apoptosis that could lead to subfertility or premature &#xd;
reproductive senescence. These alterations were associated with changes in &#xd;
epigenetic mechanisms that regulate important growth factors in the ovary. In &#xd;
addition, cannabis use during adulthood may be involved in the progression of &#xd;
gynaecological disorders such as ovarian hyperstimulation syndrome, polycystic &#xd;
ovary syndrome and ovarian cancer. More studies are necessary in order to fully &#xd;
understand the effects of cannabis on female reproductive health.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cannabis</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Developmental and reproductive toxicology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">THC</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Ovarian health and function</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">EFFECTS OF CANNABIS CONSTITUENTS ON OVARIAN HEALTH AND  FUNCTION: A FOCUS ON PRENATAL EXPOSURE</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>